143322-57-0,
(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole,
(R)-5-bromo-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indole,
(R)-5-Bromo-3-(N-methylpyrrolidine-2-ylmethyl)-1H-Indole,
(R)-5-Bromo-3-(1-methyl-pyrrolidin-2-ylmethyl)-1H-indole,
5-bromo-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-1H-Indole,
J-502238,
5-Bromo-3-(1-Methylpyrrolidin-2(R)-ylmethyl)-1H-Indole,
5-Bromo-3-[1-methylpyrrolidin-2(R)-ylmethyl]-1H-indole,
1H-Indole, 5-bromo-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-,
5-bromo-3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-indole,
5-bromo-3-[((2r)-1-methylpyrrolidin-2-yl)methyl]-1h-indole,
JCXOJXALBTZEFE-GFCCVEGCSA-N,
AK-49397,
eletriptan intermediate,
PubChem2116,
eletriptan intermediate 2,
Intermediate of Eletriptan,
UNII-XR1NS522CP,
XR1NS522CP,
SCHEMBL697582,
1H-Indole,5-bromo-3-[[(2S)-1-methyl-2-pyrrolidinyl]methyl]-,
Jsp002542,
CTK6I2568,
KS-00000IVB,
DTXSID80458106,
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole,
ACT04784,
BCP17560,
CS-B0001,
KS-00001E1C,
ZINC3779249,
ANW-57742,
MFCD00912970,
AKOS015834491,
AKOS015895955,
AM84391,
LS30062,
RL01784,
AJ-45579,
BC002231,
DS-15028,
AB1004827,
AX8018332,
TC-146487,
FT-0770635,
ST24035508,
V2433,
322B570,
I06-1272,
5-BROMO-3-(1-METHYL PYRROLIDIN-2-YL METHYL),
5-bromo-3-[[(2r)-1-methyl-2-pyrrolidinyl]methyl]-,
5-Bromo-3-(1-methyl-pyrrolidin-2-ylmethyl)-1H-indole,
5-Bromo-3-(1-methypyrrolidin-2(R)-ylmethyl)-1H-indole,
(r)-5-bromo-3-(1-methyl-2-pyrrolidinylmethyl)-1h-indole,
(R)-5-Bromo-3-(N-methylpyrrolidin-2-yl-methyl)-1H-indole,
(R)-5-bromo-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole,
(R)-5-bromo-3-(N-methylpyrrolidin-2ylmethyl)-1H-indole,
3-(N-methyl-2(R)-pyrrolidinylmethyl)-5-bromo-1H-indole,
5-bromo-3-(N-methyl-2(R)-pyrrolidinylmethyl)-1H-indole,
(R)-5-Bromo-3-[(N-methylpyrrolidin-2-yl)methyl] 1 H-indole,
(R)-5-Bromo-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole,
5-Bromo-3-((R)-1-methyl-pyrrolidin-2-ylmethyl)-1H-indole,
5-Bromo-3-(1-Methyl pyrrolidin-2(R)-yl methyl)-1H-indole,
1h-indole, 5-bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-, (r)-,
1H-Indole, 5-bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-, (R)-; (R)-5-Bromo-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole; 5-Bromo-3-[((2R)-1-methylpyrrolidin-2-yl)methyl]-1H-indole,
-1H-INDOLE,
C14H17BrN2,
-5-Bromo-3-( -1H-indole,
CS-O-31541,
CS-T-08577,
CID11185464,
EC 422-390-5,
R-5-Bromo-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole,
5-bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole,
5-bromo-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole,
(S)-5-BROMO-3-((1-METHYLPYRROLIDIN-2-YL)METHYL)-1H-INDOLE,
143322-56-9,
208464-41-9,
(R)-2-[(5-BROMO-1H-INDOL-3-YL)CARBONYL]-1-PYRROLIDINECARBOXYLIC ACID BENZYL ESTER,